Compare Johnson & Johnson (JNJ) vs Qurate Retail Inc Series A (QVCAQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Qurate Retail Inc Series A — how do they compare? Johnson & Johnson trades at $249.31 (market cap $598.96B), while Qurate Retail Inc Series A trades at $0.04 (market cap $698.27K). The key difference: Johnson & Johnson is far larger — about 857777.1× Qurate Retail Inc Series A's market cap, and Johnson & Johnson pays a 2.15% dividend while Qurate Retail Inc Series A pays none. Which is the better fit depends on your goals.
| JNJ | QVCAQ | |
|---|---|---|
Market Cap | $598.96B | $698.27K |
Volume | 6,156,228 | — |
Sector | Health | Consumer Cyclical |
52-Week High | $267.24 | $15.03 |
52-Week Low | $164.36 | $0.05 |
Enterprise Value | $631.90B | $4.73B |
Dividend Yield | 2.15% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $249.58, down 1.37% today, amid a generally bullish technical outlook with strong moving average signals. The company reported robust Q2 2026 earnings, beating EPS estimates and raising full-year guidance, with revenue growth to $94.19B in 2025 and a net income margin of 21.48%. Recent news highlights strong institutional interest and positive analyst sentiment, though the stock faces pressure from MedTech segment misses despite overall strength.
The outlook for JNJ remains positive, supported by solid fundamentals, a consistent dividend history, and upward revised earnings guidance. Key risks include competitive pressures in pharmaceuticals, regulatory hurdles, and execution challenges in the MedTech division. With a consensus price target of $279.33, representing ~12% upside, the stock offers a compelling opportunity for long-term investors, balanced by sector-specific volatility and macroeconomic factors.
QVCAQ trades at $0.05, down 14.68% today, reflecting severe financial distress with negative equity and consecutive annual losses. The stock shows a bearish technical signal, with most moving averages indicating sell pressure. Recent cash flow improvements stem from financing activities, not operations. The company celebrated 40 years of innovation with a TikTok Shop event, but fundamentals remain weak.
Outlook is highly risky due to persistent net losses, declining revenue, and negative shareholder equity. Investment opportunity is minimal without a turnaround in profitability. Key risks include high debt burden, competitive pressures in retail, and inability to achieve sustained earnings growth. Investors should avoid until operational stability is demonstrated.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Qurate Retail Inc Series A
Qurate Retail Inc, through its subsidiaries, is engaged in the video and online commerce industries. Its segments include QxH, which includes QVC U.S. and HSN market and sell a wide variety of consumer products in the United States, primarily using their televised shopping programs and via the Internet through their websites and mobile applications
Read more on QVCAQ →
